Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
JAZZ
$241.55
+0.49%
JAZZ
· Jazz Pharmaceuticals plc
$241.55
+1.18 (+0.49%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$15.50B
Shares
64.19M
Volume · Nov 13
496.8K
Avg daily vol (3M)
874.67K
All webcasts
Earnings call · FY2019 Q4
Jazz Pharmaceuticals plc (JAZZ) Q4 2019 Earnings Call
Revenue
$581.74M
+22.1% YoY
Diluted EPS
$1.29
-51.1% YoY
Gross margin
93.0%
+0.4 pp YoY
Net income
$73.99M
-53.6% YoY
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 14, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Apr 24, 2020 · complete as-filed document